You are here

Article info

Article menu
Download PDFPDF
Pancreatic cancer
HDAC2 mediates therapeutic resistance of pancreatic cancer cells via the BH3-only protein NOXA

Authors

  1. Correspondence to Dr G Schneider, Technische Universität München, Klinikum rechts der Isar, II Medizinische Klinik, Ismaninger Str 22, 81675 Munich, Germany; guenter.schneider{at}lrz.tum.de
View Full Text

Citation

Fritsche P, Seidler B, Schüler S, et al
HDAC2 mediates therapeutic resistance of pancreatic cancer cells via the BH3-only protein NOXA
Gut 2009;58:1399-1409.

Publication history

  • Revised May 19, 2009
  • Accepted June 1, 2009
  • First published June 14, 2009.
Online issue publication 
April 18, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

BMJ Publishing Group Ltd and British Society of Gastroenterology. All rights reserved.